CUSIP: 67001K202
What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 67001K202:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2020 Q1 | 0 | $0 | -$5,454,000 | 0 | |
| 2019 Q4 | 7,758,418 | $5,454,000 | -$1,304,348 | $0.70 | 5 |
| 2019 Q3 | 9,534,125 | $6,911,197 | +$1,936,945 | $0.72 | 20 |
| 2019 Q2 | 6,857,145 | $5,347,212 | -$744,740 | $0.78 | 22 |
| 2019 Q1 | 7,049,577 | $8,673,290 | -$1,079,297 | $1.23 | 24 |
| 2018 Q4 | 8,109,958 | $6,855,199 | -$12,204,716 | $0.85 | 26 |
| 2018 Q3 | 13,418,874 | $39,720,698 | -$3,661,731 | $2.96 | 43 |
| 2018 Q2 | 14,571,400 | $53,623,312 | -$2,024,604 | $3.68 | 46 |
| 2018 Q1 | 15,166,361 | $53,078,392 | +$316,670 | $3.50 | 61 |
| 2017 Q4 | 15,100,610 | $47,110,925 | -$1,383,311 | $3.12 | 71 |
| 2017 Q3 | 14,118,109 | $99,245,657 | -$6,822,472 | $7.03 | 64 |
| 2017 Q2 | 14,648,726 | $135,202,999 | +$9,221,946 | $9.23 | 70 |
| 2017 Q1 | 13,542,708 | $145,440,000 | +$9,245,592 | $10.74 | 61 |
| 2016 Q4 | 12,994,304 | $109,401,000 | +$109,300,003 | $8.42 | 59 |